Here are four key takeaways:
1. Molecular and biological technique advancements are furthering the healthcare industry’s understanding of pain.
2. Advances in pharmacogenomics and pharmacogenetics are driving the development of personalized approaches to pain management.
3. There are more than 500 companies operating in the global pain therapeutics marketplace.
4. Many of the companies operating in the market are pharmaceutical and biotechnology companies.
More articles on quality & infection control:
Coaching patients to ensure educated medical decisions: 6 observations
Only 9% of physician use EHR systems’ full capabilities: 3 insights
Senators seek $50M refund from Mylan for ‘exorbitant rates’ — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.